Rebuzzi, Antonio Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.347
EU - Europa 3.688
AS - Asia 2.941
SA - Sud America 477
AF - Africa 74
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 11.546
Nazione #
US - Stati Uniti d'America 4.263
DE - Germania 1.668
SG - Singapore 1.412
CN - Cina 779
SE - Svezia 482
BR - Brasile 389
FR - Francia 315
UA - Ucraina 295
IT - Italia 260
VN - Vietnam 198
GB - Regno Unito 181
IE - Irlanda 131
IN - India 99
ID - Indonesia 93
FI - Finlandia 75
RU - Federazione Russa 75
JP - Giappone 61
TR - Turchia 53
PL - Polonia 50
HK - Hong Kong 44
AR - Argentina 42
BD - Bangladesh 41
BE - Belgio 36
NL - Olanda 36
MX - Messico 34
CA - Canada 26
IQ - Iraq 26
ZA - Sudafrica 23
IR - Iran 21
AT - Austria 17
PK - Pakistan 16
ES - Italia 13
MA - Marocco 13
SA - Arabia Saudita 13
EC - Ecuador 11
EG - Egitto 11
AU - Australia 10
CL - Cile 10
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
JO - Giordania 8
PH - Filippine 8
UZ - Uzbekistan 8
LT - Lituania 7
PY - Paraguay 7
CH - Svizzera 6
CO - Colombia 6
ET - Etiopia 6
KR - Corea 6
LB - Libano 6
RO - Romania 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
EU - Europa 5
KE - Kenya 5
VE - Venezuela 5
AZ - Azerbaigian 4
BY - Bielorussia 4
GR - Grecia 4
IL - Israele 4
LV - Lettonia 4
PE - Perù 4
AL - Albania 3
BG - Bulgaria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
HN - Honduras 2
IS - Islanda 2
JM - Giamaica 2
KW - Kuwait 2
LY - Libia 2
MN - Mongolia 2
MU - Mauritius 2
NG - Nigeria 2
NO - Norvegia 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
CZ - Repubblica Ceca 1
EE - Estonia 1
HU - Ungheria 1
KH - Cambogia 1
MM - Myanmar 1
NZ - Nuova Zelanda 1
Totale 11.539
Città #
Singapore 812
Chandler 736
Ashburn 450
San Jose 413
New York 167
San Mateo 164
Jacksonville 162
Beijing 137
Dublin 130
Nanjing 116
Ann Arbor 100
Nürnberg 94
Jakarta 83
Los Angeles 82
Wilmington 79
Lauterbourg 77
Ho Chi Minh City 65
Dearborn 62
Munich 62
Boston 60
Marseille 59
Houston 57
Frankfurt am Main 54
Lawrence 53
Hanoi 52
Tokyo 52
Milan 51
Nanchang 51
Cattolica 46
Moscow 43
Dallas 42
Seattle 42
Chicago 41
Hefei 40
Woodbridge 39
Brussels 36
Hong Kong 35
Zhengzhou 35
Izmir 34
Fairfield 31
Lancaster 31
Buffalo 30
Redwood City 30
Kraków 28
Santa Clara 28
Shanghai 28
São Paulo 28
The Dalles 25
Bremen 24
Princeton 23
Kunming 21
Leawood 21
Fremont 20
Hebei 19
Redmond 17
Düsseldorf 16
Johannesburg 16
Nuremberg 16
Tianjin 16
Changsha 15
Mexico City 15
Norwalk 15
Detroit 14
Helsinki 14
Rome 14
San Francisco 14
University Park 14
Amsterdam 13
Guangzhou 13
Mountain View 13
Paris 13
Phoenix 13
Shenyang 13
Warsaw 13
Andover 12
Augusta 12
Boardman 12
Jiaxing 12
Kent 12
London 12
Washington 12
Baghdad 11
Orange 11
Orem 11
Simi Valley 11
Vienna 11
Ankara 10
Atlanta 10
Bexley 10
Chennai 10
Hangzhou 10
Kish 10
Toronto 10
Manchester 9
Rio de Janeiro 9
Brooklyn 8
Busto Arsizio 8
Cambridge 8
Da Nang 8
Pune 8
Totale 5.854
Nome #
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 262
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 239
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis 232
Predictors of Postoperative Atrial Fibrillation in Patients with Coronary Artery Disease Undergoing Cardiopulmonary Bypass: A Possible Role for Myocardial Ischemia and Atrial Inflammation 222
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 220
A case of fatal stent thrombosis after Carbostent implantation: Is clopidogrel alone antiplatelet therapy a safe alternative to aspirin alone antiplatelet therapy 217
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 200
Predictors of postoperative atrial fibrillation in patients with coronary artery disease undergoing cardiopulmonary bypass: a possible role for myocardial ischemia and atrial inflammation 198
Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodeling after acute myocardial infarction 196
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 195
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 194
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 190
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 189
Intramural atrial hematoma: a rare complication of a common procedure 186
Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study). 183
Post-traumatic myocardial infarction with hemorrhage and microvascular damage in a child with myocardial bridge: is coronary anatomy actor or bystander? 183
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 177
Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial 176
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 174
Presence of 'ghosts' and mortality after transvenous lead extraction 172
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 171
Positron emission tomography in acute coronary syndromes 171
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 170
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 170
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 170
Prognostic value of heart rate turbulence and its relation to inflammation in patients with unstable angina pectoris 168
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 168
The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical Implications 167
Safety of transvenous lead extraction according to centre volume: a systematic review and meta-analysis 165
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study 162
The Extent of Microvascular Damage During Myocardial Contrast Echocardiography Is Superior to Other Know Indexes of Post-Infarct Reperfusion in Predicting Left Ventricular Remodeling 162
Ethanol abolishes ischemic preconditioning in humans 161
Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients 160
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 158
Images in cardiovascular medicine. Intramyocardial spontaneous hematoma mimicking an acute myocardial infarction. 155
Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention 154
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 153
Presence of 'ghosts' and mortality after transvenous lead extraction 153
Use of Levosimendan as bridge therapy to surgical correction of post-infarction ventricular septal defect: a case report 153
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells 151
Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome 151
Myocardial infarction in isolated ventricular non-compaction: contrast echo and MRI 149
Assessment of resting perfusion defects in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography, combined first-pass/delayed contrast-enhanced magnetic resonance imaging and 99mTC-sestamibi SPECT. 149
Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. 147
Outcome of Patients Treated by Cardiac Resynchronization Therapy Using a Quadripolar Left Ventricular Lead 145
Effects of late REopening of Coronary total Occlusion on micRovascular perfusion and myocarDial function: the RECORD study 144
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial 142
Reversible microvascular dysfunction coupled with persistent myocardial dysfunction: implications for post-infarct left ventricular remodelling. 141
Contrast-enhanced magnetic resonance imaging and myocardial contrast echocardiography in patients with acute myocardial infarction: comparison with 99Technetium Sestamibi SPECT for the detection of perfusion defects. 139
[Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)] 136
Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome 136
The Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTOFFR) Study 135
Cardiac thrombi mistaken for metastasis in recurrent melanoma 134
CONTRAST MEDIUM INDUCED PD/PA RATIO (CMR) VERSUS FFR AND ADENOSINE-FREE INDEXES IN THE EVALUATION OF INTERMEDIATE CORONARY STENOSIS 133
DESolve novolimus-eluting bioresorbable coronary scaffold failure assessed by frequency-domain optical coherence tomography imaging 123
Fractional flow reserve in acute coronary syndromes and in stable ischemic heart disease: clinical implications 118
The Effects of Granulocyte Colony-Stimulating Factor in Patients with a Large Anterior Wall Acute Myocardial Infarction to Prevent Left Ventricular Remodeling: A 10-Year Follow-Up of the RIGENERA Study 118
Multiple vertebral fractures precipitate a platypnea-orthodeoxia syndrome in a patient with atrial septal defect and aortic root dilatation: when the upright position becomes intolerable 112
Stent malapposition, strut coverage and atherothrombotic prolapse after percutaneous coronary interventions in ST-segment elevation myocardial infarction 110
Cardiogenic shock due to coronary fistula: a complex phenomenon 108
Cardiac thrombi mistaken for metastasis in recurrent melanoma 106
Determinants and Evolution of Obstructive Sleep Apnea Syndrome After Myocardial Infarction 106
temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation 102
A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study. 97
Ghostbusters should come back to lead extraction arena in order to fight with ghosts: Author's reply 97
Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study 94
Use of a second, "buddy" wire during percutaneous coronary interventions: A simple solution for some challenging situations 93
Sodium bicarbonate plus N-acetylcysteine to prevent contrast-induced nephropathy in primary and rescue percutaneous coronary interventions: The BINARIO (BIcarbonato e N-Acetil-cisteina nell'infaRto mIocardico acutO) study 91
Coronary microvascular dysfunction beyond microvascular obstruction in ST-elevation myocardial infarction: Functional and clinical correlates 88
Directional atherectomy before stenting versus stenting alone in percutaneous coronary interventions: A meta-analysis. 85
Outcomes of the tacrolimus drug-eluting Janus stent: A prospective two-centre registry in high-risk patients 83
Endothelin-1 and acute myocardial infarction: A no-reflow mediator after successful percutaneous myocardial revascularization 82
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction 81
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI 73
Rescue percutaneous coronary intervention for failed thrombolysis in a patient with anomalous coronary arteries 71
The no-reflow phenomenon 69
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 66
Manual thrombus-aspiration improves myocardial reperfusion: The randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial 64
Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation 61
The complex link between oxidised low-density lipoprotein and unstable angina 60
Angiographics evalutation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI 52
Endotelin-1 and acute myocardial infarction: a no-reflow mediator after successful percutaneous myocardial revascularization 43
Totale 11.681
Categoria #
all - tutte 44.243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 0 0 0 0 0 0 0 0 0 0 0 22
2021/2022871 42 72 8 33 45 47 28 161 26 63 178 168
2022/20231.735 225 258 149 273 90 206 77 149 218 21 48 21
2023/2024784 29 192 44 22 32 208 27 16 22 28 94 70
2024/20251.355 27 48 100 74 158 29 19 65 190 151 301 193
2025/20263.473 562 83 179 349 682 167 649 158 286 224 88 46
Totale 11.681